Used as a selective antagonist for the TRPM8 ion channel, TCS 2210 is primarily employed in scientific research to study cold-sensing pathways and pain mechanisms related to temperature perception. It helps investigate the role of TRPM8 in conditions such as neuropathic pain, migraine, and overactive bladder. Due to its ability to block menthol- and cold-induced responses, it is a valuable tool in pharmacological studies aiming to develop new analgesic or urological treatments. Its selectivity makes it suitable for in vitro and in vivo experiments where precise modulation of TRPM8 activity is required.